Acurx Pharmaceuticals (ACXP) Cash & Current Investments (2020 - 2026)
Acurx Pharmaceuticals' Cash & Current Investments came in at $10.7 million for Q2 2026, up 76.4% from $6.06 million a year earlier and up 15.1% from the prior quarter.
Powered by 
Analysis
Acurx Pharmaceuticals (ACXP) Cash & Current Investments (2020 - 2026) Analysis & Trends
At the end of FY2025, Acurx Pharmaceuticals' Cash & Current Investments was $7.56 million, up 103.8% from FY2024.
- Cash & Current Investments carries a five-year compound annual growth rate of 18.9% (FY2020 to FY2025).
- Going back by year, Cash & Current Investments was $3.71 million in FY2024 (-50.4%), $7.47 million in FY2023 (-18.0%), $9.11 million in FY2022 (-29.7%) and $12.96 million in FY2021 (+308.1%).
- The Q2 2026 figure represents the highest quarterly Cash & Current Investments since Q1 2022.
- Year-over-year, Cash & Current Investments has increased for four consecutive quarters, with growth averaging 20.2% over the last eight quarters.
- The fastest year-over-year change in Cash & Current Investments over five years came in Q3 2021 (growth of 324.4%), and the weakest in Q4 2024 (a decline of 50.4%).
- Business Quant data shows ACXP's Cash & Current Investments at $9.3 million (Q1 2026), $7.56 million (Q4 2025) and $5.91 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Acurx Pharmaceuticals | 4.86 Mn | -28.61 Mn | - | 10.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.70 Mn |
| Mar 31, 2026 | 9.30 Mn |
| Dec 31, 2025 | 7.56 Mn |
| Sep 30, 2025 | 5.91 Mn |
| Jun 30, 2025 | 6.06 Mn |
| Mar 31, 2025 | 4.64 Mn |
| Dec 31, 2024 | 3.71 Mn |
| Sep 30, 2024 | 5.76 Mn |
| Jun 30, 2024 | 6.36 Mn |
| Mar 31, 2024 | 8.92 Mn |
| Dec 31, 2023 | 7.47 Mn |
| Sep 30, 2023 | 7.05 Mn |
| Jun 30, 2023 | 9.15 Mn |
| Mar 31, 2023 | 7.18 Mn |
| Dec 31, 2022 | 9.11 Mn |
| Sep 30, 2022 | 10.61 Mn |
| Jun 30, 2022 | 9.09 Mn |
| Mar 31, 2022 | 11.08 Mn |
| Dec 31, 2021 | 12.96 Mn |
| Sep 30, 2021 | 14.46 Mn |
API Access
Acurx Pharmaceuticals Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ACXP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "ACXP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ACXP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();